|
NO167087C
(no)
|
1985-10-25 |
1991-10-02 |
Secr Defence Brit |
Fremgangsmaate for fremstilling av en nitratester.
|
|
US5561227A
(en)
|
1991-07-23 |
1996-10-01 |
Schering Corporation |
Process for the stereospecific synthesis of azetidinones
|
|
LT3300B
(en)
|
1992-12-23 |
1995-06-26 |
Schering Corp |
Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor
|
|
RU2175324C2
(ru)
|
1995-09-01 |
2001-10-27 |
Фармация Энд Апджон Компани |
Фенилоксазолидиноны, имеющие с-с-связь с 4-8-членными гетероциклическими кольцами
|
|
WO2000005214A2
(en)
|
1998-07-24 |
2000-02-03 |
Pfizer Inc. |
Isoquinolines as urokinase inhibitors
|
|
WO2003018549A2
(en)
|
2001-08-30 |
2003-03-06 |
Chemocentryx, Inc. |
Bicyclic compounds as inhibitors of chemokine binding to us28
|
|
RS20050019A
(sr)
|
2002-07-12 |
2007-09-21 |
Sanofi - Aventis Pharma Deutschland Gmbh., |
Heterociklično supstituisani benzoilkarbamidi,postupak za njihovu proizvodnju i njihova primena kao leka
|
|
JP4516430B2
(ja)
|
2002-12-20 |
2010-08-04 |
メルク・シャープ・エンド・ドーム・コーポレイション |
１−（アミノ）インダン並びに（１，２−ジヒドロ−３−アミノ）−ベンゾフラン、ベンゾチオフェン及びインドール
|
|
CA2509406C
(en)
|
2002-12-23 |
2012-07-03 |
Janssen Pharmaceutica N.V. |
Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
|
|
GB0510204D0
(en)
|
2005-05-19 |
2005-06-22 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
|
JP2009530389A
(ja)
*
|
2006-03-21 |
2009-08-27 |
エピックス デラウェア， インコーポレイテッド |
Ｓ１ｐ受容体調節化合物及びその使用
|
|
US8962825B2
(en)
|
2006-10-30 |
2015-02-24 |
Glaxosmithkline Intellectual Property Development Limited |
Hydroxamates as inhibitors of histone deacetylase
|
|
US20090137549A1
(en)
|
2006-11-09 |
2009-05-28 |
Paul John Edward |
Novel compounds useful for the treatment of degenerative & inflamatory diseases
|
|
WO2010056788A1
(en)
|
2008-11-17 |
2010-05-20 |
Merck Sharp & Dohme Corp. |
Anti-hypercholesterolemic compounds
|
|
ES2427917T3
(es)
|
2009-02-10 |
2013-11-04 |
Astrazeneca Ab |
Derivados de triazolo [4,3-b] piridazina y sus usos para el cáncer de próstata
|
|
WO2011036889A1
(ja)
|
2009-09-25 |
2011-03-31 |
武田薬品工業株式会社 |
複素環化合物
|
|
GB201002563D0
(en)
|
2010-02-15 |
2010-03-31 |
Cambridge Entpr Ltd |
Compounds
|
|
MA34300B1
(fr)
|
2010-05-13 |
2013-06-01 |
Amgen Inc |
Composés azotés hétérocycliques convenant comme inhibiteurs de la pde10
|
|
US8946230B2
(en)
|
2010-05-13 |
2015-02-03 |
Amgen Inc. |
Aryl- and heteroaryl- nitrogen-heterocyclic compounds as PDE10 inhibitors
|
|
WO2012082947A1
(en)
|
2010-12-16 |
2012-06-21 |
Irm Llc |
Compounds and compositions as tgr5 agonists
|
|
EP2545964A1
(en)
|
2011-07-13 |
2013-01-16 |
Phenex Pharmaceuticals AG |
Novel FXR (NR1H4) binding and activity modulating compounds
|
|
WO2013169622A1
(en)
|
2012-05-09 |
2013-11-14 |
Zoetis Llc |
Azetidine derivatives as antiparasitic agents
|
|
TW201408652A
(zh)
|
2012-07-11 |
2014-03-01 |
Hoffmann La Roche |
作爲ＲＯＲｃ調節劑之芳基磺內醯胺衍生物
|
|
BR112015010649A2
(pt)
|
2012-11-16 |
2017-07-11 |
Bristol Myers Squibb Co |
moduladores de gpr40 à base de pirrolidina
|
|
MX2016004934A
(es)
|
2013-10-17 |
2016-12-20 |
Abbvie Deutschland |
Derivados de aminotetralina y aminoindano, composiciones farmaceuticas que los contienen, y su uso en terapia.
|
|
CA2934700A1
(en)
|
2014-01-06 |
2015-07-09 |
Rhizen Pharmaceuticals Sa |
Glutaminase inhibitors
|
|
FR3017867A1
(fr)
*
|
2014-02-21 |
2015-08-28 |
Inventiva |
Nouveaux composes de type phenylazetidine carboxylate ou carboxamide
|
|
DK3140296T3
(en)
|
2014-05-07 |
2018-07-23 |
Bristol Myers Squibb Co |
PYRROLIDIN GPR40 MODULATORS FOR TREATMENT OF DISEASES SUCH AS DIABETES
|
|
EP3191453B1
(en)
|
2014-09-09 |
2019-10-23 |
Bristol-Myers Squibb Company |
Phenyl-(aza)cycloalkyl carboxylic acid gpr120 modulators
|
|
WO2017019540A2
(en)
|
2015-07-24 |
2017-02-02 |
Yale University |
Inhibitors of n-linked glycosylation and methods using same
|
|
HRP20230201T1
(hr)
|
2015-10-12 |
2023-03-31 |
Chong Kun Dang Pharmaceutical Corp. |
Oksadiazol aminski spojevi derivati kao inhibitor histonske deacetilaze 6 i farmaceutska kompozicija koja sadrži iste
|
|
ES2975689T3
(es)
|
2016-01-29 |
2024-07-11 |
Ono Pharmaceutical Co |
Derivado de tetrahidronaftaleno
|
|
LT3426243T
(lt)
|
2016-03-09 |
2021-08-10 |
Raze Therapeutics, Inc. |
3-fosfogliceratdehidrogenazės inhibitoriai ir jų panaudojimas
|
|
US20200321533A1
(en)
|
2016-05-24 |
2020-10-08 |
President And Fellows Of Harvard College |
Compounds for organic light emitting diode materials
|
|
MX385718B
(es)
|
2016-06-13 |
2025-03-18 |
Gilead Sciences Inc |
Compuestos moduladores de fxr (nr1h4).
|
|
CA3252823A1
(en)
|
2016-06-13 |
2025-02-25 |
Gilead Sciences, Inc. |
Substituted tert-butyl-3-(2-chloro-phenyl)-3-hydroxyazetidine-1-carboxylate compounds
|
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
|
AR110988A1
(es)
|
2017-02-21 |
2019-05-22 |
Sanofi Sa |
Compuestos de azetidina como moduladores de gpr119 para el tratamiento de la diabetes, la obesidad, la dislipidemia y trastornos relacionados
|
|
EP3666770A4
(en)
|
2017-08-07 |
2021-04-07 |
Joint Stock Company "Biocad" |
NEW HETEROCYCLIC COMPOUNDS AS CDK8 / 19 INHIBITORS
|
|
CA3087886A1
(en)
|
2018-01-19 |
2019-07-25 |
Idorsia Pharmaceuticals Ltd |
C5a receptor modulators
|
|
US10695334B2
(en)
|
2018-08-16 |
2020-06-30 |
Boehringer Ingelheim International Gmbh |
Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
|
|
CA3109090A1
(en)
|
2018-08-17 |
2020-02-20 |
F. Hoffmann-La Roche Ag |
Diagnostic and therapeutic methods for the treatment of breast cancer
|
|
JPWO2020071550A1
(ja)
|
2018-10-04 |
2021-09-24 |
京都薬品工業株式会社 |
Ｃｄｋ８阻害剤およびその用途
|
|
KR102659859B1
(ko)
|
2018-10-30 |
2024-04-25 |
길리애드 사이언시즈, 인코포레이티드 |
알파4β7 인테그린의 억제를 위한 화합물
|
|
CN111484479B
(zh)
|
2019-01-25 |
2023-06-13 |
四川科伦博泰生物医药股份有限公司 |
氮杂环化合物、包含其的药物组合物及其制备方法和用途
|
|
CA3143280A1
(en)
|
2019-07-03 |
2021-01-07 |
F. Hoffmann-La Roche Ag |
Heterocyclic monoacylglycerol lipase (magl) inhibitors
|
|
CN114302873A
(zh)
|
2019-08-20 |
2022-04-08 |
小野药品工业株式会社 |
具有s1p5受体激动活性的化合物的盐和晶形
|
|
CN112887914A
(zh)
*
|
2019-11-30 |
2021-06-01 |
深圳市海思半导体有限公司 |
终端间定位方法及装置
|
|
CN111704613B
(zh)
|
2020-06-23 |
2021-07-06 |
中国人民解放军军事科学院军事医学研究院 |
咪唑类衍生物及其作为trpv4抑制剂的用途
|
|
EP4267117B1
(en)
|
2020-12-23 |
2026-04-08 |
Celgene Corporation |
Carboxylic acid containing indanyl compounds for the treatment of neurodegenerative diseases
|
|
US11919879B2
(en)
*
|
2021-06-16 |
2024-03-05 |
Celgene Corporation |
Carboxylic acid containing azetidinyl compounds for the treatment of neurodegenerative diseases
|